Trial Profile

Stricture Definition and Treatment (STRIDENT) Drug Therapy Study

Status: Active, no longer recruiting

Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Adalimumab (Primary) ; Purines
Indications Crohn's disease
Focus Therapeutic Use
Acronyms STRIDENT

Most Recent Events

05 Oct 2022 According to ClinicalTrials.gov record, the recruitment status of this study is unknown because the information has not been verified recently (last verified OCT 2020).
23 May 2021 Results presented at the Digestive Disease Week 2021
22 Oct 2020 Planned End Date changed from 1 Sep 2020 to 1 Sep 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com